Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia

International Psychogeriatrics

Volumn 12, Issue 4, 2000, Pages 537-545

  Spigset, Olav ^a,b   Wilhelmsson, Christer ^a   Mjörndal, Tom ^a   Eriksson, Sture ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; RADIOLIGAND; SEROTONIN 2A RECEPTOR; BIOLOGICAL MARKER; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AGED; AGITATION; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; RATING SCALE; RECEPTOR BINDING; RECEPTOR DENSITY; THROMBOCYTE; BLOOD; CASE CONTROL STUDY; COGNITION; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CITALOPRAM; COGNITION; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0034351785     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610200006645     Document Type: Article

References (44)

1. 3H] paroxetine binding to 5-HT uptake sites in Alzheimer's disease
2. Human brain cortex and platelet serotonin-2 receptor binding properties and their regulation by endogenous serotonin
3. Serotonin uptake in the blood platelets of Alzheimer's disease patients
4. Serotonin 5-HT2 receptor binding on blood platelets as a stade dependent marker in major affective disorder
5. 2 receptor binding in blood platelets - A peripheral marker for depression?
6. 2 receptors in Alzheimer's disease
7. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease
8. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life
9. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases
10. 2A receptor
11. Serotonin receptor changes in dementia of the Alzheimer type
12. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides
13. 5-HT2 receptors in dementia of Alzheimer type: A quantitative autoradiographic study of frontal cortex and hippocampus
14. 125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue
15. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician
16. Intact brain serotonin system in vascular dementia
17. From transmittors to treatment: The pharmacotherapy of behavioural disturbances in dementia
18. 2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease
19. 2A receptors unchanged by antidepressant treatment
20. 14C]5-hydroxytryptamine
21. Alzheimer's disease: Changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors - An autoradiographic study
22. Uptake of serotonin into platelets of senile dementia of the Alzheimer type patients
23. Serotonin uptake and its kinetics in platelets of women with Alzheimer's disease
24. Peripheral serotonin in Alzheimer's disease
25. Protein measurement with folin phenol reagent
26. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets
27. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
28. Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging
29. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders
30. 2 receptor binding characteristics in the individual and the putative regulation by serotonin
31. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms
32. Long-term treatment of elderly individuals with emotional disturbances: An open study with citalopram
33. Functional assessment staging (FAST)
34. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment
35. Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type
36. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions
37. 3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy
38. Aging and Alzheimer's disease. Altered cortical serotonergic binding
39. 2A receptor binding in anorexia nervosa and bulimia nervosa
40. Excretion of citalopram in breast milk
41. 3H]LSD) binding in healthy volunteers
42. 3H]LSD): Intra- and interindividual variability
43. Peripheral serotoninergic receptor sensitivity in senile dementia of the Alzheimer type